{"id":"F2015L01704","name":"National Health (Pharmaceutical Benefits - Early Supply) Amendment Instrument 2015 (No. 9) - specification under subsection 84AAA(2) (PB 103 of 2015)","slug":"national-health-pharmaceutical-benefits-early-supply-amendment-instrument-2015-no-9-specification-un","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":93515,"registerId":"commonwealth-F2015L01704-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health (Pharmaceutical Benefits - Early Supply) Amendment Instrument 2015 (No. 9) - specification under subsection 84AAA(2) (PB 103 of 2015)","content":"---\nmeta-content-style-type: text/css\nmeta-content-type: application/xhtml+xml; charset=utf-8\nmeta-generator: Aspose.Words for .NET 20.2\ntitle: Normal.dot\n---\n\n?xml version=\"1.0\" encoding=\"utf-8\" standalone=\"no\"?>\n\n![](image.001.png)\n\n \n\nPB 103 of 2015\n\nNational Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 9) – specification under subsection 84AAA(2)\n\n \n\nNational Health Act 1953\n\n \n\nI, PAUL CREECH, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.\n\nDated     23 October  2015\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nPAUL CREECH\n\nFirst Assistant Secretary (Acting)\n\nPharmaceutical Benefits Division\n\nDepartment of Health\n\n \n\n \n\n \n\n___________________________________________________________________________  \n\n\n \n\nAmendment determination – Pharmaceutical Benefits – Early Supply\n\n \n\n \n\n1 Name of Instrument\n\n \n\n(1)           This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 9) – specification under subsection 84AAA(2).\n\n \n\n(2)           This Instrument may also be cited as PB 103 of 2015.\n\n \n\n2 Commencement\n\n \n\nThis Instrument commences on 1 November 2015.\n\n \n\n3 Amendment of PB 30 of 2009\n\n \n\nSchedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).\n\n \n\n \n\nSchedule 1 Amendments\n\n \n\n[1]                Schedule 1, after entry for Pindolol in the form Tablet 15 mg\n\ninsert:\n\n- Ponatinib Tablet 15 mg (as hydrochloride) Oral 60 5 60\n- Tablet 45 mg (as hydrochloride) Oral 30 5 30\n\n\n \n\n \n","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2254},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"This is a routine administrative addition to the existing early supply framework established by the 2009 parent instrument. It does not expand the legislative scheme beyond its original purpose of specifying which drugs qualify for early supply."},"complexity_factors":["Single, discrete amendment inserting one pharmaceutical entry with two line items","No interpretation section or defined terms","No conditional logic, exceptions, or nested provisions","Straightforward numerical specifications (quantity/days/quantity format)"],"plain_english_summary":"**What this does:**\n\nThis instrument adds the medicine **Ponatinib** to the list of pharmaceuticals that can be supplied early under the Pharmaceutical Benefits Scheme (PBS).\n\n**Why it matters:**\n\nNormally, PBS rules require patients to wait a set period between collecting repeat prescriptions. \"Early supply\" rules allow patients to get their next batch of medication before that waiting period ends—useful for travel or avoiding stock shortages. This amendment gives patients taking Ponatinib access to those flexible arrangements.\n\n**The specifics:**\n\nThe update adds two tablet strengths to the early supply list:\n*   **15mg tablets** – permitting early supply of up to 60 tablets\n*   **45mg tablets** – permitting early supply of up to 30 tablets\n\nThe numbers set out exactly how much can be supplied and how often, ensuring the concession is used appropriately.\n\n**Who is affected:**\n\nPatients prescribed Ponatinib under the PBS, and the pharmacists who dispense it."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-pharmaceutical-benefits-early-supply-amendment-instrument-2015-no-9-specification-un","history":"/api/acts/national-health-pharmaceutical-benefits-early-supply-amendment-instrument-2015-no-9-specification-un/history","analysis":"/api/acts/national-health-pharmaceutical-benefits-early-supply-amendment-instrument-2015-no-9-specification-un/analysis","conflicts":"/api/acts/national-health-pharmaceutical-benefits-early-supply-amendment-instrument-2015-no-9-specification-un/conflicts","importantCases":"/api/acts/national-health-pharmaceutical-benefits-early-supply-amendment-instrument-2015-no-9-specification-un/important-cases","documents":"/api/acts/national-health-pharmaceutical-benefits-early-supply-amendment-instrument-2015-no-9-specification-un/documents"}}